Reuters logo
BRIEF-Theraclion announces FDA authorization to start US trial for immunotherapy and echotherapy combination on breast cancer
2017年6月26日 / 下午4点18分 / 4 个月内

BRIEF-Theraclion announces FDA authorization to start US trial for immunotherapy and echotherapy combination on breast cancer

June 26 (Reuters) - THERACLION SA:

* THERACLION ANNOUNCES FDA AUTHORIZATION TO START U.S. TRIAL FOR IMMUNOTHERAPY AND ECHOTHERAPY COMBINATION ON BREAST CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below